UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites ▼ | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
Q6RKB0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
Q6P4P2 | G-protein coupled receptor-associated protein LMBRD2B |
|
1 | 0 |
|
Q5XJN2 | Gamma-interferon-inducible lysosomal thiol reductase |
|
1 | 0 |
|
A0A8M9PYT6 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A4FUN8 | Rhodopsin |
|
1 | 0 |
|
P0DM64 | Melanocortin-2 receptor accessory protein 2B |
|
1 | 0 |
|
A0A8M9QLP2 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A0A8M9QAX1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8M9PUS4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
Q7T070 | Ammonium transporter Rh type B |
|
1 | 0 |
|
Q6NUX8 | Rho-related GTP-binding protein RhoA-A |
|
1 | 0 |
|
F1QRB8 | Plasminogen activator inhibitor 1 |
|
1 | 0 |
|
A8E7N9 | Growth/differentiation factor 6-B |
|
1 | 0 |
|
A0A8M6Z3D5 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
A0A8M9QHQ9 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
Q9DGJ3 | NPC intracellular cholesterol transporter 2 |
|
1 | 0 |
|
Q6GMK6 | Tetraspanin-9 |
|
1 | 0 |
|
Q1JPS6 | Melanopsin-like |
|
1 | 0 |
|
Q5IGR8 | Exostosin-1a |
|
1 | 0 |
|
A0A8M3ATS4 | Hyaluronidase |
|
1 | 0 |
|
A0A8M9Q7A3 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
Q1LYG4 | Cyclic AMP-responsive element-binding protein 3-like protein 3-B |
|
1 | 0 |
|
B1P2E8 | Pannexin |
|
1 | 0 |
|
A0A8M9PUZ6 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
Q6TLE6 | Calcium release-activated calcium channel protein 1 |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024